Sysmex

Skip Navigation

SearchMenu

About Sysmex

Press Release

▼ Old News

2015rss

Dec. 17, 2015 Products & Solution Products & Solution
Sysmex Becomes the First in Japan1 to Realize Automated Detection of Lymph Node Metastasis of Non-Small-Cell Lung Cancer
- Application of the OSNA® Method Expanded to Include Non-Small-Cell Lung Cancer, Following Application for Breast Cancer, Colorectal Cancer and Stomach Cancer -
Dec. 04, 2015 Products & Solution Products & Solution
Blood-based RAS biomarker test now available in Germany
Dec. 01, 2015 Management & Business Management & Business
Sysmex Establishes New Subsidiary in Ghana
- Reinforcing the Company’s Business Foundation in the Markets of West and Central Africa -
Nov. 13, 2015 Research & Development Research & Development
Sysmex Opens Lab within the National Cancer Center to Promote the Development of New Cancer Diagnosis Methods
Nov. 13, 2015 Investor Relations Investor Relations
Sysmex Wins 20th “IR Grand Prix Award” from Japan Investor Relations Association
Nov. 05, 2015 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2016 (PDF:717KB)
Nov. 05, 2015 Investor Relations Investor Relations
Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2015, and Revision of Full-Year Financial Results Forecasts (PDF:110KB)
Nov. 05, 2015 Investor Relations Investor Relations
Announcement Regarding Dividends from Surplus (Commemorative Dividend) (PDF:101KB)
Oct. 07, 2015 Investor Relations Investor Relations
Sysmex Selected by the Securities Analysts Association of Japan for Excellence in Corporate Disclosure and Excellence in Disclosure to Individual Investors
Oct. 06, 2015 Research & Development Research & Development
Sysmex Wins Awards in 2015 Kinki Local Commendation for Inventions
Sep. 30, 2015 Other Other
Sysmex Extends Funding for Kobe University Graduate School of Medicine Course
Sep. 28, 2015 Management & Business Management & Business
Sysmex Selected for Inclusion in the Asia Pacific Index of the Dow Jones Sustainability Indexes for Fourth Consecutive Year
Sep. 17, 2015 Research & Development Research & Development
Sysmex to Open New R&D Open Innovation Lab
Sep. 15, 2015 Management & Business Management & Business
Sysmex to Expand U.S. Reagent Factory
- Aiming to Meet Growing Demand in the Americas -
Sep. 01, 2015 Products & Solution Products & Solution
Sysmex Launches its Next-Generation Models in the Sediment Urinalysis Testing Field, the UF-5000/4000/3000 Fully Automated Analyzers of Formed Elements in Urine
Aug. 27, 2015 Products & Solution Products & Solution
Sysmex Receives in Vitro Diagnostic Approval for Manufacturing and Sales of Three Platelet Aggregation Agonist Reagent Kits
- Pursuing Efficiency and Standardization by Automating Platelet Aggregation Tests -
Aug. 05, 2015 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2016 (PDF:681KB)
Jul. 06, 2015 Management & Business Management & Business
Sysmex Completes Expansion of Reagent Factory in Germany
- Increasing Reagent Production Capacity by 50% to Meet Growing Demand in EMEA -
Jun. 03, 2015 Management & Business Management & Business
Sysmex to Participate in the Global Health Innovative Technology Fund
Jun. 01, 2015 Management & Business Management & Business
Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based Molecular Testing Services and Products to Support the Development of Precision Medicine in Oncology
May. 26, 2015 Management & Business Management & Business
RIKEN GENESIS Co., Ltd., Becomes Japan's First Registered CLIA Lab
May. 19, 2015 Products & Solution Products & Solution
Sysmex Accredited ISO 15195 Laboratory medicine - Requirements for reference measurement laboratories
- Initiatives toward Further Standardization of Clinical Testing and Quality Improvement -
May. 12, 2015 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2015 (PDF:601KB)
May. 12, 2015 Investor Relations Investor Relations
Sysmex Announces Changes from Financial Results Forecasts, Year-End Dividend for the Fiscal Year Ended March 31, 2015, and Dividend Policy (PDF:106KB)
May. 12, 2015 Management & Business Management & Business
Sysmex Announces New Group Mid-Term Management Plan
- Preparing the Company to Move to the Next Stage by Reinforcing Growth and Profitability, Investing in Growth and Promoting Transformation - (PDF:178KB)
Apr. 10, 2015 Management & Business Management & Business
Sysmex to Participate in "Global Human Resource Development Community" Japan Public-Private Partnership Student Study Abroad Program
Apr. 09, 2015 Products & Solution Products & Solution
Sysmex Signs Agreement with Cambodia's Ministry of Health Related to Scientific Support Activities Aimed at Enhancing the Quality of Clinical Testing
Apr. 02, 2015 Management & Business Management & Business
Medicaroid Corporation Commences Full-Fledged Development of Medical Robots
Apr. 01, 2015 Products & Solution Products & Solution
Insurance Coverage for Sysmex's Reagent to Monitor Therapeutic Gains on Chronic Myelogenous Leukemia (CML) (ipsogen BCR-ABL1 Mbcr IS-MMR DX Kit)
Mar. 26, 2015 Management & Business Management & Business
Sysmex to Establish the Global Communication Center as a Place to Facilitate Unfettered Communication and Prompt Ideas
Mar. 26, 2015 Other Other
Sysmex to Be Special Sponsor of the Kobe Marathon 2015
- We are pleased to have sponsored this exciting event since its inception in 2011 -
Mar. 11, 2015 Other Other
FY2014 Nakatani Award and Research Grant Recipients Announced (PDF:96KB)
Mar. 09, 2015 Management & Business Management & Business
Sysmex Invests in iPS PORTAL, Inc., Aiming to Contribute to Regenerative Medicine
Mar. 05, 2015 Management & Business Management & Business
Announcement of Organizational and Personnel Changes (PDF:231KB)
Feb. 04, 2015 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2015 (PDF:808KB)
Jan. 28, 2015 Products & Solution Products & Solution
Sysmex Launches the CS-1600 Automated Blood Coagulation Analyzer, a New Compact Model in the Hemostasis field
Jan. 05, 2015 Products & Solution Products & Solution
Hepatic fibrosis test reagent (HISCL M2BPGi Assay Kit) receives approval for health insurance coverage
- Speedy blood sample-based test for measuring the progression of hepatic fibrosis from chronic hepatitis to cirrhosis of the liver -
Back to "About Sysmex"